Content
All Posts > Content under Pharma/Biotech
Cannabis Central: How Well Do The Two New TSX Cannabis Indexes Track The Industry's Stock Performance?
Article By:
Lorimer Wilson
Read
Tuesday, April 7, 2020 4:28 PM EDT
As a result of the growing interest in the marijuana industry the S&P/TSX recently launched two indices, the S&P/TSX Cannabis Index and the S&P/MX International Cannabis Index to track the performance of specific baskets of cannabis companies.
Cannabis Central's New Non-Penny Pot Stock Index Was UP 6.2% Monday Vs.2.9% For The Total Sector
Article By:
Lorimer Wilson
Read
Tuesday, April 7, 2020 3:38 AM EDT
The total cannabis sector of 319 stocks increased 2.9% on Monday compared to the new Non-penny Pot Stock Index which advanced 6.2%. All but 5 of the 32 constituents stocks in the NPSI went up.
Digital Therapeutics Market To Witness Exponential Growth Amid COVID-19 Outbreak
Article By:
Steve Blade
Read
Monday, April 6, 2020 10:45 AM EDT
Digital therapeutics which empower patients & healthcare providers with intelligent and accessible tools for addressing a wide range of conditions through data-driven interventions has set foothold in North America during the fallout of COVID-19.
The Canadian Cannabis Report - Monday, April 6
Article By:
James Coleman
Read
Monday, April 6, 2020 10:40 AM EDT
It was a very challenging week for Canadian cannabis companies. The relative strength indicator decrease of 14.1% was more than the overall index decline of 12.4%.
Cannabis Central: Only 7 Pot Stocks Now Have Market Caps Above $1B
Article By:
Lorimer Wilson
Read
Monday, April 6, 2020 8:48 AM EDT
At the height of the cannabis stock frenzy back in March/April of 2019, there were 17 companies out of a total of 319 companies listed on the various stock exchanges with valuations over $1 billion but now there are only 7. Here is the list.
Antibe Therapeutics: A Breakthrough In NSAIDs
Article By:
Kieran O'Dea
Read
Sunday, April 5, 2020 11:37 PM EDT
I don't usually recommend an individual stock, let alone a biotech company like Antibe Therapeutics, but here I am...
In this article: ATBPF
Volatile Coronavirus Biotech Stock Plays
Article By:
Rod Raynovich
Read
Saturday, April 4, 2020 9:48 PM EDT
Here are many of the well-followed life science stocks that are in the news with diagnostics, drugs and vaccines that may have an impact on the COVD-19 pandemic.
Cannabis Central: Sector Declined 11.4% Last Week; Only These 5 Advanced
Article By:
Lorimer Wilson
Read
Saturday, April 4, 2020 7:51 PM EDT
Only 32 of the universe of 319 pot stocks closed last week above US$1/share declining -10.8%, on average, versus -6.2% the previous week, and slightly less than the -11.4% decline, on average, for the entire sector.
Week In Review: Signs Of Life After Coronavirus -- China Biopharma Scores $721 Million In Deals
Article By:
ChinaBio® Today
Read
Saturday, April 4, 2020 4:57 PM EDT
Shanghai ZhenGe Biotech, a China CDMO, completed a $51 million Series A financing round led by Shanghai-based healthcare investment firm Lyfe Capita. The company will use the proceeds for additional hires and to expand its Shanghai R&D center
Cannabis Central: Sector Declined 2.5% On Friday With Only These 9 Non-Penny Pot Stocks Advancing
Article By:
Lorimer Wilson
Read
Saturday, April 4, 2020 4:47 PM EDT
Today's article identifies the three non-penny pot stocks that advanced by 5% or more on Friday, the 10 stocks that declined by more than 5% and eight of the remaining stocks that warrant mentioning.
Every Vaccine And Treatment In Development For COVID-19, So Far
Article By:
Jeff Desjardins
Read
Thursday, April 2, 2020 5:10 AM EDT
As the number of confirmed COVID-19 cases continues to skyrocket, healthcare researchers around the world are working tirelessly to discover new life-saving medical innovations.
Cannabis Central: Carnage Continued On Wednesday (-6.2%) With Only 3 Stocks Advancing
Article By:
Lorimer Wilson
Read
Wednesday, April 1, 2020 11:06 PM EDT
Only 2 pot stocks trade above $20 with 3 trading between $10 and $20 and 32 trading between $1 and $10 at an average price of $3.42. On Wednesday the cannabis sector of 319 stocks declined 6.2% with only 3 of these 37 non-penny stocks advancing.
In this article: ACRGF, CGC, LQSIF, NEPT, LABS, CRLBF, CRBP, IIPR, NBEV, GRWG, CRON, TLRY, PYX, ACB, APHA, CWBHF, CURLF, HRVSF, HEXO, KERN, OGI, VFF, GNLN, AYRWF, CCHWF (NOW CBSTF), ZYNE
Cannabis Central: Sector Improved Marginally Tuesday (-1.3%); Here Are The Top Winners 7 Losers
Article By:
Lorimer Wilson
Read
Tuesday, March 31, 2020 11:59 PM EDT
Today's article identifies the 6 non-penny stocks in the sector that increased by a minimum of 5%, the 6 that declined in excess of 5% and 6 of the remaining stocks that warrant mentioning.
